发明授权
- 专利标题: Triazolopyridine compounds
- 专利标题(中): 三唑并吡啶化合物
-
申请号: US13613291申请日: 2012-09-13
-
公开(公告)号: US09062045B2公开(公告)日: 2015-06-23
- 发明人: Chao Chen , Haibing Deng , Haibing Guo , Feng He , Lei Jiang , Fang Liang , Yuan Mi , Huixin Wan , Yao-Chang Xu , Hongping Yu , Ji Yue (Jeff) Zhang
- 申请人: Chao Chen , Haibing Deng , Haibing Guo , Feng He , Lei Jiang , Fang Liang , Yuan Mi , Huixin Wan , Yao-Chang Xu , Hongping Yu , Ji Yue (Jeff) Zhang
- 申请人地址: CH Basel
- 专利权人: Novartis AG
- 当前专利权人: Novartis AG
- 当前专利权人地址: CH Basel
- 代理商 Qian Zhang; Jing G. Sun
- 主分类号: A61K31/397
- IPC分类号: A61K31/397 ; C07D471/04 ; C07D519/00 ; A61K31/437 ; A61K31/496 ; A61K31/5377 ; A61K31/5513 ; A61K45/06 ; C07D491/107
摘要:
The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).
公开/授权文献
- US20130245002A1 Triazolopyridine Compounds 公开/授权日:2013-09-19